Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients.

BACKGROUND We analyzed the incidence of acute kidney injury and chronic renal failure in chronic myeloid leukemia (CML) patients using imatinib and investigated whether there is a relation between duration of imatinib therapy and decrease in estimated glomerular filtration rate (GFR). PATIENTS AND METHODS One hundred five CML patients on imatinib therapy… CONTINUE READING